Johnson & Johnson (JNJ) news

Older JNJ news events, each with the realized, point-in-time move the market made — page 10 of 10. Back to the JNJ overview → · Full JNJ reaction history →

Latest news

Recent JNJ events, each with its measured reaction. (Page 10 of 10.)

DateHeadlineEventSource5-minTo close
Form 10-K JOHNSON & JOHNSON For: Dec 31SEC filing · Form 10-KSEC EDGAR+0.12%+0.67%
Form 13F-HR JOHNSON & JOHNSON For: Dec 31SEC filing · Form 13F-HRSEC EDGAR-0.10%-0.23%
Johnson & Johnson to Participate in the Barclays 26th Annual Global Healthcare ConferencePress releaseBusiness Wire+0.81%+1.24%
Johnson & Johnson to Participate in the Leerink Global Biopharma ConferencePress releaseBusiness Wire+0.44%-0.74%
Biosense Webster Presents Late-Breaking Data from inspIRE and admIRE Clinical Trials at AF SymposiumPress releasePR Newswire-0.69%-0.52%
Johnson & Johnson to Participate in the Raymond James 45th Annual Institutional Investors ConferencePress releaseBusiness Wire-0.69%-0.52%
Form 8-K JOHNSON & JOHNSON For: Jan 23SEC filing · Form 8-KSEC EDGAR-0.59%-0.12%
Johnson & Johnson Reports Q4 and Full-Year 2023 ResultsPress releaseBusiness Wire-0.59%-0.12%
Biosense Webster Announces Regulatory Approval of VARIPULSE™ Pulsed Field Ablation (PFA) Platform in JapanPress releasePR Newswire+0.19%+0.00%
Form DEFA14A JOHNSON & JOHNSONSEC filing · Form DEFA14ASEC EDGAR-0.28%+0.15%
Johnson & Johnson to Acquire Ambrx, Advancing Next Generation Antibody Drug Conjugates to Transform the Treatment of CancerPress releaseBusiness Wire-0.28%+0.15%
Johnson & Johnson Announces Quarterly Dividend for First Quarter 2024Press releaseBusiness Wire+0.44%+1.94%
Key Talc Lawyers: Planned “Prepack” J&J Bankruptcy is “Farce” and Improper Litigation TacticPress releaseBusiness Wire-0.73%+1.39%
Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter ResultsPress releaseBusiness Wire-0.45%+0.04%
Johnson & Johnson to Participate in the 42nd Annual J.P. Morgan Healthcare ConferencePress releaseBusiness Wire-0.42%-0.81%
Form 8-K JOHNSON & JOHNSON For: Dec 05SEC filing · Form 8-KSEC EDGAR+0.46%-0.16%
Form 8-K JOHNSON & JOHNSON For: Nov 30SEC filing · Form 8-KSEC EDGAR-0.40%-1.20%
Johnson & Johnson Announces Key Drivers for Long-Term Competitive Growth at Enterprise Business ReviewPress releaseBusiness Wire+0.46%-0.16%
Publication in Bloomberg Law: ‘A Third J&J Bankruptcy Attempt Won’t Resolve Victims’ Talc Claims’ by Andy BirchfieldPress releaseBusiness Wire-0.12%+0.03%
Form 8-K JOHNSON & JOHNSON For: Nov 30SEC filing · Form 8-KSEC EDGAR-0.18%+1.24%
Johnson & Johnson MedTech Acquires Laminar, Inc.Press releaseBusiness Wire-0.16%+1.58%
Johnson & Johnson Names Eugene A. Woods, Chief Executive Officer of Advocate Health, to its Board of DirectorsPress releaseBusiness Wire-0.18%+1.24%
Form 8-K JOHNSON & JOHNSON For: Nov 21SEC filing · Form 8-KSEC EDGAR-0.13%+0.15%
Talc Lawyer: Johnson & Johnson Settlements Undermine Bankruptcy Strategy, Serve as Acknowledgment That Baby Powder Contained AsbestosPress releaseBusiness Wire+0.01%+0.19%
Johnson & Johnson to Host Enterprise Business ReviewPress releaseBusiness Wire-0.05%+0.40%
Ethicon Introduces ETHIZIA™ Hemostatic Sealing Patch, Clinically Proven to Stop Disruptive BleedingPress releasePR Newswire+0.16%+0.92%
Form 13F-HR JOHNSON & JOHNSON For: Sep 30SEC filing · Form 13F-HRSEC EDGAR-0.26%-0.68%
Key Lawyer in Johnson & Johnson Talc Litigation Supports Call to Rethink Legal Strategies in Light of Failure of Texas Two-StepPress releaseBusiness Wire-0.38%+0.09%
New Biosense Webster QDOT MICRO™ Catheter Data Demonstrate Very High-Power, Short-Duration Ablations Improved Quality of Life and Reduced Healthcare Utilization for AFib PatientsPress releasePR Newswire+0.31%+1.71%
Cancer Victims Support Sen. Richard Blumenthal in Urging Johnson & Johnson to Accept ResponsibilityPress releaseBusiness Wire+0.07%+0.65%
Form 10-Q JOHNSON & JOHNSON For: Oct 01SEC filing · Form 10-QSEC EDGAR+0.46%+0.58%
Form 8-K JOHNSON & JOHNSON For: Oct 20SEC filing · Form 8-KSEC EDGAR+0.60%+0.15%
Johnson & Johnson Announces Departure of Ashley McEvoy, Tim Schmid Named Executive Vice President, Worldwide Chairman of MedTechPress releaseBusiness Wire+0.60%+0.15%

Each headline opens its own page with the full realized reaction — the move the market actually made, measured from the news timestamp.

Stop guessing what the event means.

claude mcp add news-quantified
Get free API keyTry the playground